.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
McKesson
Accenture
Argus Health
Daiichi Sankyo
QuintilesIMS
Fuji
Baxter
McKinsey

Generated: December 14, 2017

DrugPatentWatch Database Preview

Diphenhydramine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for diphenhydramine hydrochloride and what is the scope of diphenhydramine hydrochloride patent protection?

Diphenhydramine hydrochloride
is the generic ingredient in sixteen branded drugs marketed by Mcneil Cons, Alra, Anabolic, Barr, Elkins Sinn, Halsey, Heather, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lederle, LNK, Mk Labs, Mutual Pharm, Newtron Pharms, Nexgen Pharma Inc, Perrigo, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sandoz, Sun Pharm Industries, Superpharm, Teva, Valeant Pharm Intl, Vangard, Watson Labs, Whiteworth Town Plsn, Cenci, Usl Pharma, Bundy, Kv Pharm, Naska, Pharm Assoc, Alpharma Us Pharms, App Pharms, Bel Mar, Eurohlth Intl Sarl, Hospira, Lyphomed, Mylan Institutional, Watson Labs Teva, West-ward Pharms Int, Wyeth Ayerst, Abraxis Pharm, Fresenius Kabi Usa, Intl Medication, Parke Davis, Morton Grove, Cumberland Swan, Hi Tech Pharma, Silarx, Warner Chilcott, Pfizer, Bionpharma Inc, Strides Pharma, and Bayer Hlthcare, and is included in ninety-two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for diphenhydramine hydrochloride. Seventeen suppliers are listed for this compound.

Pharmacology for diphenhydramine hydrochloride

Medical Subject Heading (MeSH) Categories for diphenhydramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Hikma Intl PharmsDIPHENHYDRAMINE HYDROCHLORIDEdiphenhydramine hydrochlorideCAPSULE;ORAL083567-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsDIPHENHYDRAMINE HYDROCHLORIDEdiphenhydramine hydrochlorideINJECTABLE;INJECTION083533-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson Labs TevaDIPHENHYDRAMINE HYDROCHLORIDEdiphenhydramine hydrochlorideINJECTABLE;INJECTION080873-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettDIPHENHYDRAMINE HYDROCHLORIDEdiphenhydramine hydrochlorideELIXIR;ORAL080939-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettDIPHENHYDRAMINE HYDROCHLORIDEdiphenhydramine hydrochlorideCAPSULE;ORAL080868-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettDIPHENHYDRAMINE HYDROCHLORIDEdiphenhydramine hydrochlorideCAPSULE;ORAL080868-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson Labs TevaDIPHENHYDRAMINE HYDROCHLORIDEdiphenhydramine hydrochlorideINJECTABLE;INJECTION080873-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pvt FormDIPHENHYDRAMINE HYDROCHLORIDEdiphenhydramine hydrochlorideCAPSULE;ORAL083027-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pvt FormDIPHENHYDRAMINE HYDROCHLORIDEdiphenhydramine hydrochlorideELIXIR;ORAL085287-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsDIPHENHYDRAMINE HYDROCHLORIDEdiphenhydramine hydrochlorideCAPSULE;ORAL080728-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Accenture
Cipla
Queensland Health
Mallinckrodt
Novartis
McKinsey
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot